SCHEMBL18123325

SCHEMBL18123325

O=C1CN(C2CN(C(=O)OCc3ccccc3)C2)CCN1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ CYP2C19 P33261 1/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ GAA P10253 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ TMEM97 Q5BJF2 4/20 0.44
▸ SIGMAR1 Q99720 4/20 0.44
▸ HTR1A P08908 2/20 0.44
▸ HRH2 P25021 2/20 0.44
▸ HRH1 P35367 2/20 0.44
▸ HRH3 Q9Y5N1 2/20 0.44
▸ ADRA2C P18825 1/20 0.44
▸ GRIN2B Q13224 4/20 0.43
▸ GLA P06280 1/20 0.43
▸ HTR2C P28335 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19966274 0.84 KMT2A (0.45) SMN1; SMN2NPC1RAB9ACYP2C19KMT2A
SCHEMBL28636570 0.84 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ACYP2C19KMT2A
SCHEMBL92518 0.84 L3MBTL1 (0.56) SMN1; SMN2NPC1RAB9ACYP2C19KMT2A
SCHEMBL23164394 0.82 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19KMT2A
SCHEMBL31663743 0.80 HTR2C (0.52) SMN1; SMN2NPC1RAB9ACYP2C19KMT2A
SCHEMBL30485023 0.80 HTR2C (0.52) SMN1; SMN2NPC1RAB9ACYP2C19KMT2A
SCHEMBL3074986 0.79 MEN1 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19KMT2A
SCHEMBL18123323 0.79 MEN1 (0.50) SMN1; SMN2NPC1RAB9ACYP2C19KMT2A
SCHEMBL23821182 0.79 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9ACYP2C19KMT2A
SCHEMBL1570844 0.78 MEN1 (0.57) SMN1; SMN2NPC1RAB9ACYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016157074-A1 6-MORPHOLINYL-2-PYRAZOLYL-9H-PURINE DERIVATIVES AND THEIR USE AS PI3K INHIBITORS DAIICHI SANKYO COMPANY, LIMITED (JP) 2016-10-06 — — WO disclosed
Send feedback